Photoplethysmographic Scaling of Dyspnoea
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Respiratory Failure
Related studies linked through entity extraction aliases.
Efficacy of CONvalescent Plasma in Patients With COVID-19 Treated With Mechanical Ventilation
- Status
- COMPLETED
- Phase
- PHASE2
A Pilot Study Investigating the Detection of Episodes of Severe Patient-Ventilator Asynchrony
- Status
- UNKNOWN
- Phase
- N/A
Awake-Prone Positioning Strategy for Hypoxic Patients With COVID-19
- Status
- COMPLETED
- Phase
- NA
Nebulised Heparin in Patients With Severe COVID-19
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Real Time Evaluation of Dynamic Changes of the Lungs During Respiratory Support of VLBW Neonates Using EIT
- Status
- COMPLETED
- Phase
- N/A
Absent Visitors: The Wider Implications of COVID-19 on Non-COVID Cardiothoracic ICU Patients, Relatives and Staff
- Status
- UNKNOWN
- Phase
- N/A
Reduced Anticoagulation Targets in ECLS (RATE)
- Status
- COMPLETED
- Phase
- PHASE3
Ventilator-associated Injury (VAI) in Chronic Home Mechanical Ventilation
- Status
- COMPLETED
- Phase
- N/A
High Flow Nasal Cannula Oxygen During Sedation for Video-assisted Thoracoscopic Surgery
- Status
- UNKNOWN
- Phase
- PHASE2
Tenecteplase in Patients With COVID-19
- Status
- COMPLETED
- Phase
- PHASE2
Veno-venous Extracorporeal Membrane Oxygenation (VV-ECMO) Heparin Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
Effects of mTOR Inhibition With Sirolimus (RAPA) in Patients With COVID-19 to Moderate the Progression of ARDS
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Stress Related Disorders in Family Members of COVID-19 Patients Admitted to the ICU
- Status
- COMPLETED
- Phase
- N/A
Exercise Capacity Under Various FiO2 and Oxygen Flow Rates Using HFNC
- Status
- COMPLETED
- Phase
- NA
One Year Follow-ups of Patients Admitted to Spanish Intensive Care Units Due to COVID-19
- Status
- COMPLETED
- Phase
- N/A
HFNC and NIV for COVID-19 Complicated by Respiratory Failure
- Status
- COMPLETED
- Phase
- N/A
Pemziviptadil (PB1046), a Long-acting, Sustained Release Human VIP Analogue, Intended to Provide Clinical Improvement to Hospitalized COVID-19 Patients at High Risk for Rapid Clinical Deterioration and Acute Respiratory Distress Syndrome (ARDS).
- Status
- TERMINATED
- Phase
- PHASE2
Infusion of Prostacyclin (Iloprost) vs Placebo for 72-hours in COVID-19 Patients With Respiratory Failure
- Status
- COMPLETED
- Phase
- PHASE2
Driving Pressure and Mortality: in the Pediatric Intensive Care Unit (PICU)
- Status
- COMPLETED
- Phase
- N/A